Taylor Porter, MD
Psychiatry · Lawrence, KSNPI 1760423362
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Alkermes, Inc. accounts for 75.3% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $5,931 and has fallen 90.8% since, to $548 in 2025.
Across 122 payments — averaging $65.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$6K
- Johnson & Johnson$404
- AbbVie$282
- Vanda Pharmaceuticals Inc.$168
- Takeda Pharmaceuticals U.S.A., Inc.$127
- Axsome Therapeutics, Inc.$117
- plus $872 from 16 others
What the payments were for
- Speaking & faculty fees$4,60058%
- Travel & lodging$1,02413%
- Food & beverage$2,34229%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$23,392
- ARISTADA INITIO$5,848
How this compares
$7,966 in reported general payments places this provider in the 85th percentile of 259 psychiatry providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 19 | $140,877 |
| AplenzinBupropion Hbr | 13 | $79,294 |
| VraylarCariprazine Hcl | 33 | $49,580 |
| RexultiBrexpiprazole | 20 | $28,363 |
| DayvigoLemborexant | 21 | $9,561 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 65 | $7,612 |
| Aripiprazole | 60 | $6,223 |
| Oxcarbazepine | 28 | $5,455 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,033 |
| Methylphenidate Hcl | 41 | $4,936 |
| Clozapine | 39 | $4,501 |
| Rivastigmine | 13 | $4,488 |
| Duloxetine Hcl | 138 | $3,884 |
| Buspirone Hcl | 151 | $3,211 |
| Lisdexamfetamine Dimesylate | 12 | $3,178 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $89 | $140,87719 claims |
| Bausch Health US, LLCAplenzin | $25 | $79,29413 claims |
| AbbVieVraylar | $282 | $49,58033 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $15 | $28,36320 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $127 | $5,03311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 259 psychiatry providers in Kansas.
Other psychiatry in Lawrence
- Hiten SoniLawrence$11K
- Nicholas EvangelidisLawrence$2K
- Kristin CunninghamLawrence$2K
- David WichmanManhattan$613K
- Kevin MaysLeawood$548K
- Sheldon PreskornWichita$498K
- James OwensSalina$433K
- Sasha HamdaniOverland Park$104K
- Christine GlennKansas City$58K
- Heidi OgdenWichita$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.